Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 584, pseudogene (RNU6-584P) is a pseudogene belonging to the family of small nuclear RNAs (snRNAs), specifically related to U6 snRNA[1][6]. U6 snRNA plays an essential role in the catalytic core of the spliceosome, which removes introns from precursor mRNA during splicing; however, pseudogenes like RNU6-584P are non-functional copies produced through retrotransposition or duplication events and do not participate in canonical splicing biology[1][6][7]. These pseudogenes are abundant in vertebrate genomes and serve primarily as genomic markers of retrotranspositional activity, rather than as active molecular targets or therapeutic receptors[7]. As such, RNU6-584P is not functionally associated with disease processes, drug interactions, or used as a biomarker or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 584, pseudogene (RNU6-584P).